Boston Scientific Corporation (NYSE: BSX) has announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain. The Intracept system, a basivertebral nerve ablation therapy, will be an addition to the Boston Scientific chronic pain portfolio that includes spinal cord stimulation, radiofrequency ablation and an interspinous spacer procedure.
Read the full article: Boston Scientific Closes Acquisition of Relievant Medsystems, Inc. //
Source: https://www.prnewswire.com/news-releases/boston-scientific-closes-acquisition-of-relievant-medsystems-inc-301992180.html